Page last updated: 2024-11-06

mitomycin and Prostatitis

mitomycin has been researched along with Prostatitis in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Prostatitis: Infiltration of inflammatory cells into the parenchyma of PROSTATE. The subtypes are classified by their varied laboratory analysis, clinical presentation and response to treatment.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beltrami, P1
Ruggera, L1
Cazzoletti, L1
Schiavone, D1
Zattoni, F1

Trials

1 trial available for mitomycin and Prostatitis

ArticleYear
Are prostate biopsies mandatory in patients with prostate-specific antigen increase during intravesical immuno- or chemotherapy for superficial bladder cancer?
    The Prostate, 2008, Aug-01, Volume: 68, Issue:11

    Topics: Aged; Antibiotics, Antineoplastic; BCG Vaccine; Biopsy; Drug Monitoring; Epirubicin; Humans; Immunot

2008